Mirum Pharmaceuticals Inc (MIRM)
$85.00 -1.61% Close Oct 30, 2026 Live
Mirum Pharmaceuticals stock today
Mirum Pharmaceuticals closed at $85.00 on October 30, 2026, down 1.61% on the day. Over the past year it returned +17.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $5.18 billion.
$60.00$80.00$100.00$120.00
NovJan 2026MarMayJulSep
| Period | MIRM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.6% | -0.9% |
| 3 months | -24.5% | +2.1% |
| Year to date | +7.6% | +11.7% |
| 1 year | +17.7% | +12.4% |
| 3 years | +211.9% | +88.5% |
| 5 years | +435.3% | +76.0% |
Key statistics
- Market value
- $5.18B
- Price / sales
- 8.4
- 52-week range
- $64.10 to $128.57
- Next report
- Nov 3, 2026
About Mirum Pharmaceuticals
Develops pharmaceutical treatments for rare liver and metabolic diseases.
Sector: Health Care
More on Mirum Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +55% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $5,353 today
No forecast, no recommendation. This page describes Mirum Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.